Evaluation and Referral Guidelines for Urinary Cellular Casts

Laboratory Evaluation

Detect proteinuria with a dip‑stick ≥ 1+ and confirm quantitatively by a 24‑hour urine collection or a spot urine protein‑to‑creatinine ratio. [1][2]
An active urinary sediment (≥ 5 red blood cells / high‑power field and ≥ 5 white blood cells / high‑power field) in the absence of infection supports glomerular pathology. 1
Serum creatinine and blood urea nitrogen should be measured to assess renal insufficiency; calculate eGFR for functional staging. 3
Serum electrolytes are recommended to identify metabolic complications associated with renal disease. 1

Urgent referral when protein excretion exceeds 1 g/24 h (or spot protein‑to‑creatinine ratio > 1.0). 4
Referral also indicated when protein excretion exceeds 0.5 g/24 h (or ratio > 0.5) if the finding is persistent, rising, or accompanied by other renal disease markers. [1][4]

Nephrology referral (immediate) for any patient in whom cellular casts are identified in the urine. [3][5]
Referral for patients with proteinuria meeting the thresholds above. [1][2]
Referral for patients demonstrating renal insufficiency (elevated creatinine/BUN) or other glomerular markers. [3][4]
In suspected lupus nephritis, nephrology referral and renal biopsy for ISN/RPS classification are advised unless contraindicated. [1][2]

Conduct concurrent urologic assessment in patients > 35 years of age. [3][6]
Add urologic evaluation for individuals with a history of smoking or occupational chemical exposure. 4
Include urologic work‑up for patients with prior gross hematuria. [6][4]
Evaluate patients reporting irritative voiding symptoms. 4

Presence of cellular casts should trigger full renal evaluation regardless of anticoagulant use or level. [3][6]
Persistence of casts after treatment of a presumed urinary‑tract infection warrants immediate nephrologic investigation. 5
Microscopic urine analysis is essential; dip‑stick testing alone cannot identify casts. 6
Even when glomerular disease is confirmed, a risk‑based urologic assessment should not be omitted. [3][5]

Active lupus nephritis is defined by proteinuria > 0.5 g/day and the presence of cellular casts (RBC, hemoglobin, granular, tubular, or mixed) according to ACR criteria. 1
Renal biopsy is recommended for classification of lupus nephritis unless a strong contraindication exists. [1][2]

Dysmorphic red blood cells comprising > 80 % of urinary RBCs indicate glomerular bleeding, whereas a predominance of normal‑shaped RBCs (>80 %) suggests a lower urinary‑tract source. 7
The presence of > 5 % acanthocytes in the urine sediment is diagnostic for glomerular disease. 8
Red blood cell casts are pathognomonic for glomerulonephritis and reflect active glomerular inflammation. 7
Tea‑colored urine is a classic visual clue pointing toward glomerular hematuria. 9
Phase‑contrast microscopy is the preferred technique for detecting dysmorphic RBCs in urine sediment. 9
Percentages of dysmorphic RBCs between 20 % and 80 % are indeterminate and may arise from either glomerular or lower‑tract bleeding. 7

Significant proteinuria is typically detected as ≥ 1+ (often ≥ 2+) on dipstick testing. 9
Nephrotic‑range proteinuria (≥ 1 g/24 h) warrants comprehensive evaluation and referral to nephrology. 7
Lower‑grade proteinuria (≥ 0.5 g/24 h) should be investigated if it persists, increases, or is accompanied by other signs of renal parenchymal disease. 7
A spot urine protein‑to‑creatinine ratio ≥ 0.5 can be used as a reliable alternative to a 24‑hour collection. 10

White‑blood‑cell casts may appear in urine but are not specific for glomerular pathology. 8
Lipiduria can be observed in nephrotic‑syndrome presentations associated with glomerulonephritis. 8
“Active” urinary sediment is defined as ≥ 5 RBCs/hpf and ≥ 5 WBCs/hpf in the absence of infection. 10

Adults: Microscopic hematuria is defined as ≥ 3 RBCs/hpf on two of three properly collected specimens. 7
Children: Microscopic hematuria is defined as ≥ 5 RBCs/hpf on two of three consecutive specimens. 11

Evidence of renal insufficiency (elevated serum creatinine and blood urea nitrogen) may accompany the urinary findings. 7

Routine microscopic examination of urine sediment for erythrocyte morphology and for red‑cell casts or acanthocytes should be performed in any patient with suspected glomerular disease. 12
Serial monitoring of hematuria intensity and persistence provides prognostic information, particularly in IgA nephropathy and systemic vasculitis. 12